Methods: Three villages in Western Cambodia were selected for the study based on high reported Plasmodium falciparum incidence. A census was conducted at the beginning of the study, including demographic information and travel history. The total population was 1766. Cross-sectional surveys were conducted every three months from June 2013 to June 2014. Plasmodium infections were detected using an ultra-sensitive, high-volume, quantitative polymerase chain reaction (uPCR) technique. Clinical episodes were recorded by village health workers. The geographic coordinates (latitude and longitude) were collected for all houses and all participants were linked to their respective houses using a demographic surveillance system. Written informed consent was obtained from all participants. 2.3-19. 8). Subclinical infections of both P. vivax and P. falciparum were associated with clinical episodes of the same species (AOR: 5.8; CI: 1.5-19.7 for P. falciparum and AOR: 14.6; CI: 8.6-25.2 for P. vivax) and self-reported overnight visits to forested areas (AOR = 3.8; CI: 1.8-7. 7 for P. falciparum and AOR = 2.9; CI: 1.7-4.8 for P. vivax). Discussion: Spatial clustering within the villages was transient, making the prediction of spatial clusters difficult. Interventions that are dependent on predicting spatial clusters (such as reactive case detection) would only have detected a small proportion of cases unless the entire village was screened within a limited time frame and with a highly sensitive diagnostic test. Subclinical infections may be acquired outside of the village (particularly in forested areas) and may play an important role in transmission.
Introduction
In much of the Greater Mekong Subregion (GMS) malaria case numbers have been decreasing and nations are moving from malaria control to elimination. Village- Within the remaining malaria endemic areas in the GMS, malaria risk is heterogeneously distributed and the complete interruption of malaria transmission has thus far been elusive. In many parts of the GMS malaria persists in clusters along international borders as a result of a complex combination of political, environmental, and socio-economic factors that are not completely understood.
Migration of both mosquitoes and humans can lead to the reintroduction of parasites to regions that might otherwise be malaria free The main goals of this research were to investigate potential associations between 1) subclinical Plasmodium infections and clinical malaria episodes, 2) travelling to or spending the night in the forest and clinical episodes or subclinical Plasmodium infections, and 3) spatial and spatio-temporal clustering of clinical episodes or subclinical Plasmodium infections within villages in Pailin Province, Cambodia.
Methods

Study sites
The study area consisted of three villages in Pailin Province, Cambodia, near the international border with Thailand ( Fig. 1) . In 2004 Pailin reported some of the Article No~e00447 highest annual parasite incidences (API) in Cambodia, with API above 160/per 1000 people per year for both P. falciparum and P. vivax. By 2013 this incidence had fallen to around 10/1000 for P. falciparum and 20/1000 for P. vivax. The study villages were selected based on P. falciparum incidence in 2012 and are adjacent to each other, covering an area approximately ten km long and four km wide.
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Data collection
Detailed demographic and geographic surveys were conducted beginning in June 2013 and ending in December of 2014. During the study period, first-line treatment for P. falciparum and for P. vivax was dihydroartemisinin-piperaquine. Primaquine was not used for P. vivax due to a lack of availability of G6PD testing. In addition radical cure of P. vivax with primaquine was not recommended in the national treatment guidelines at the time of the study.
Individuals who agreed to participate in the study had their age and sex recorded and were given an identification code. The geographic coordinates (latitude and longitude) for all houses in the study villages were recorded and each house was assigned an identification code. All participating individuals were linked through a demographic surveillance system to their respective houses. All participants provided written informed consent. ). During the cross-sectional surveys a mobile clinic was established in a central location within each village, usually in the village school. Village volunteers were trained to assist in the surveys and they went house-to-house to inform and invite all residents to participate. Surveys took place over several days and were usually followed up one week later in order to survey participants who were absent during the survey. Within each survey, house members attended as groups and passed through a series of desks where they provided informed consent, they were registered, weighed, measured, had their tympanic temperature taken, completed a short survey form, provided a venous blood sample and received a consultation with a nurse if necessary. During the screenings, 3 mL of blood was collected from each adult participant (500 uL from children six months to five years old), any malaria symptoms (e.g. fever, chills) were noted, and the blood was analyzed using an ultra-sensitive quantitative polymerase chain reaction method (uPCR), with a lower level of detection of 22 parasites per mL (described in detail in and for the present analysis were considered "clinical" episodes of P. falciparum or P. vivax malaria beginning in June 2013 and running through December 2014 (M0-M18). Both clinical episodes and subclinical infections were then linked to houses of residence for analysis.
Brief travel history and bednet usage interviews were also conducted during each of the three-monthly cross-sectional surveys. Participants were asked if they had travelled to another location or spent the night in the forest within the last two weeks.
The original census population was treated as a cohort for this analysis. Some individuals moved into the villages during the study period but were not included in this analysis as their data do not account for their previous exposures and environments. Participants who moved out of the cohort and villages during the
were included in this analysis.
Analysis
The outcome variables for these analyses were clinical episodes (of P. falciparum or P. vivax, separately) and subclinical infections (also of P. falciparum or P. vivax separately). Both clinical malaria episodes and subclinical infections detected by uPCR during surveys can occur multiple times within individual participants and all episodes were included in the analysis. It was not possible to determine whether or not recurrent malaria infections in individuals were new infections or recrudescences, as the genetic material was typically insufficient for genotyping.
Also, relapse infections in P. vivax cannot be distinguished from recrudescent infection. Therefore, individuals who had either a confirmed clinical episode or uPCR-confirmed subclinical infection with malaria (for P. falciparum and P. vivax separately) were coded with a "1" regardless of their number of infections.
Participants who never presented at a clinic with symptomatic malaria and who never had malaria parasites detected by uPCR during the study period were coded as "0". A quantitative variable was included to account for the number of screenings attended by individuals, with some individuals only attending 1 screening and others attending all 5.
In order to test for house-level clustering of infections, two house-[ 2 7 _ T D $ D I F F ] level covariates were also included to indicate whether or not there were secondary infections within the house: one indicating secondary clinical episodes and one indicating secondary uPCR detected infections. This covariate excluded the index case.
Categorical predictor variables were created for participant sex and age, with age being aggregated into groups based on work behaviors of villagers (age groups 0-9; 10-45; and 46 plus). Two predictor categorical variables related to human movement patterns were also created, one based on the participant reporting falciparum and clinical P. vivax) was generated (Fig. 2) . A categorical variable for village was included both to account for unmeasured village-specific factors and clustering at the village level.
Exploratory analysis
Exploratory analyses investigated outcome and predictor variables with regard to outcome variables as well as the timing between episodes that occurred within house and within individuals. Contingency tables were used to look for associations between subclinical infections and clinical malaria episodes, between cases in houses and individuals in those houses, and between spending the night in the forest or away from the village and both clinical episodes and subclinical infections. Odds ratios were calculated for binary variables and Chi-squared or Fisher's exact tests were used where appropriate (for variables with multiple levels).
Exploratory spatial analysis
Counts of clinical episodes, subclinical infections and population numbers were aggregated at the individual house level for spatial analysis. Clinical episodes were aggregated into three-month periods matching the timing of the cross sectional 
Logistic regression
Logistic regression was used to calculate model adjusted odds ratios for predictor variables with regard to clinical episodes and uPCR detected subclinical infections of both P. falciparum and P. vivax (a total of 4 regressions). All regressions, bivariate and univariate analyses were done using R CRAN (http://www.R-project.
org/).
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Ethics approval
Results
A total of 1,766 villagers were recorded in the demographic surveillance system, of which 1,520 responded to interviews regarding bednet use, travel or forest dwelling behavior, and 1,593 participated in the cross-sectional surveys using uPCR. During the study period 21 participants (21/1,766; 1.2%) were diagnosed with clinical P. falciparum episodes and 81 participants (81/1,766; 4.6%) were diagnosed with clinical P. vivax episodes. Of those who participated in the blood screening, 3.3% (53/1,593) were found to carry subclinical P. falciparum infections and 8.6% (137/1,593) were found to carry subclinical P. vivax infections, and 19% (308/1,593) had Plasmodium infections that could not be differentiated at the species level because of low parasite densities. Most clinical episodes (53/81 for P. vivax and 17/21 for P. falciparum) occurred in one study village (PDB) ( Table 1) .
During the travel surveys 39.7% (604/1,520) of participants reported having spent the night away from the village and 8.6% (131/1,520) reported having spent the night in a forest. Bednet use during the night previous to the questioning was reported by 99% (1,516/1,520) of interviewed participants.
Both the prevalence of uPCR detected malaria and the incidence of clinical cases decreased throughout the study period, during which a well-functioning village malaria worker system was maintained. No bednet distributions were undertaken during the study period.
As previously noted, subclinical P. vivax infections in study participants were repeatedly detected through successive uPCR screenings, suggesting relatively long-term chronic infections up to several months The results indicated a strong, positive association between having travelled to forested areas and being detected with subclinical P. falciparum and P. vivax (uPCR P. falciparum UOR: 4.1; CI: 2.1-8.0; uPCR P. vivax UOR: 3.40; CI: 2.2-5.4).
We did not find a statistically significant association between clinical or subclinical infection and a history of travel or between clinical malaria and having spent the night in the forest. Bednet usage was uniformly high (99% reported using bednets) and was not further analysed.
Exploratory spatial data analysis
Most clinical P. falciparum episodes, clinical P. vivax episodes, subclinical P.
falciparum and subclinical P. vivax infections (both total counts and proportion positive) occurred within one study village: PDB (Fig. 3) . Conversely, the proportion of villagers reporting having travelled or spent the night in the forest was higher in other villages.
There was no statistically significant difference between participants with and without clinical falciparum episodes with regard to living near another house with a clinical falciparum infection. Participants with a clinical vivax episode lived closer to other houses with clinical vivax episodes (a median distance of 48 meters compared to 103 meters for participants without a clinical vivax episode; Wilcox rank sum test p-value 0.0062).
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The scan statistics indicated clusters of clinical P. vivax episodes in each of the study villages (Fig. 3) . The relative risk of infection within these clusters was significantly higher in comparison to the population outside of the cluster. Single (Fig. 3) .
[ 3 9 _ T D $ D I F F ] 3.2. Logistic regressions and adjusted odds ratios
.1. Clinical P. falciparum [ 4 1 _ T D $ D I F F ] and P. vivax malaria episodes
The strongest predictor for clinical P. falciparum malaria episodes was living in a house with another person that had a clinical P. falciparum malaria episode. Individuals who lived in a house with someone who had a clinical P. falciparum malaria had 7 times the odds (adjusted odds ratio (AOR): 7.15; CI: 2.4-20. 5) of having a clinical P. falciparum episode (Table 3) . Having a subclinical P. village PDB. Participants who were from PDB had an AOR of 2.1 (CI: 1.2-3.9) when compared to village KL.
Distance to the nearest house with a clinical infection showed no statistical significance for either clinical P. falciparum or P. vivax episodes after controlling for covariates.
[ 4 2 _ T D $ D I F F ] 3.2.2. Subclinical P. falciparum and P. vivax infections
The largest predictors of having a subclinical P. falciparum infection was selfreported traveling to the forest (Adjusted Odds Ratio (AOR) = 3.5; CI: 1.6-7.1) or having a clinical P. falciparum malaria episode during the study period (AOR: 5.7; CI: 1.4-19.6) ( Table 5 ).
Several factors were statistically significant predictors of subclinical P. vivax infection. The strongest predictor was having a clinical P. vivax malaria episode during the study period (AOR: 14.1; CI: 8.2-24.5) ( Table 6 ). Individuals with subclinical P. vivax infections tended to be male (AOR: 2.4; CI: 1.6-3.8). The risk of being detected with subclinical P. vivax infections increased with age, participants above age nine having 2.6 times the odds (CI: 1.5-4.9) of carrying P. vivax infections and those above age 45 with 2.9 times the odds (CI: 1.4-5.9) of being detected with subclinical P. vivax infection (both in comparison to the 0-9 age group). Staying overnight in a forested area also had a strong association with subclinical P. vivax infections (AOR = 2.4; CI: 1.4-4.1). Cohort members who participated in more surveys also had a higher odds of being detected with a subclinical P. vivax infection (AOR = 1.5; CI: 1.3-1.8).
[
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This study found clustering of both clinical cases subclinical parasite carriage at multiple scales within the villages. While the study villages are within three to four kilometers from each other, the majority of clinical malaria episodes and subclinical infections occurred in one village (PDB), which was home to 67%
(70/102) of all malaria episodes and 46% (88/190) of all subclinical infections. (Tables 2 and 3 ). In four out of the seven houses with multiple P. falciparum episodes during the study period, the timing between episodes was within a month of each other (Table 2) (Table 1) .
Participants who reported spending the night in a nearby forest were more likely to have subclinical infections (both P. vivax and P. falciparum) during the study period when compared to participants who did not report a forest visit. This Some participants were found subclinically infected by P. vivax after having presented with a clinical episode. Also in village PDB, the cluster of subclinical P. vivax infections occurred after the cluster of clinical P. vivax malaria episodes. Since curative doses of primaquine were not used in the villages at the time of the study, it is plausible that these were relapse infections rather than reinfections.
In the presence of viable mosquito vectors, individuals with subclinical infections over long periods of time may be important contributors to ongoing transmission in this region. If P. vivax is targeted for elimination it will be important to address chronic, subclinical infections. Our data suggest that spatial targeting at levels smaller than the village may not adequately address this potential reservoir.
Finally, both clinical and subclinical P. falciparum infections in these study villages decreased to almost zero in all study villages despite the absence of any additional targeted interventions other than sustaining a well-functioning village based malaria worker system providing early diagnosis and treatment. P. vivax infections also decreased but the decrease was less pronounced than that of P. Other factors may have led to the decline in P. falciparum in these study villages, but they occurred in the absence of expensive and labour heavy approaches (e.g. screen and treat approaches). In order to see a similar effect on P. vivax incidence it will be necessary to target liver stage parasites with radical treatment, as well as subclinical, chronic infections.
There are several limitations to this study. It is possible that some villagers with febrile illness attended health facilities outside of the village clinics and these cases would have been missed in this analysis. Some of the uPCR detected infections could not be identified at the species level. Low numbers of P. falciparum infections, especially clinical P. falciparum cases, made sophisticated analyses difficult and led to wide confidence intervals around model predictions. However, all significant covariates in the statistical models were also significant in univariate analyses and while large odds ratios may be over-predictions they indicate strong correlations. Participation in surveys was associated with increased odds of an individual being detected with at least one subclinical P. vivax infection. The numbers of people detected with subclinical P. vivax infections here may therefore be an underestimate.
Another limitation to this work is reporting bias in bednet use and travel interviews. Participants may have forgotten important travel histories or may have been hesitant to admit travelling to specific areas (for example, to forests for illegal logging). This type of bias is likely to have a stronger influence with regard to false negatives than to false positives. Positive associations are likely to remain despite this bias whereas a finding of no correlation may be the result of under-reporting.
Finally, the variable for having spent the night in the forest within the previous two weeks may be prone to bias in that no specific definition of "forest" was given by either interviewer or interviewee. It is therefore possible that different participants have different understandings of what constitutes a forest. Furthermore, the question regarding forest stays and travelling did not specify the amount of time spent either in the forest or away from the village. If forests are an important source of Plasmodium infections then it would be valuable to know if longer exposure to forests is associated with higher risk of infection. Future research will aim to address this question.
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These data contribute to a growing body of literature that illustrate the inherent difficulties of predicting spatio-temporal clustering of malaria at scales above the household level and below the village level. While helpful for directly (human-tohuman) transmitted diseases with relatively short incubation periods (e.g. smallpox), predicting the transmission of vector borne diseases is more challenging. This is likely the result of complex transmission patterns and frustrates interventions that are based on prediction of space time occurrence of malaria at these scales (such as reactive case detection). Finally, elimination of P.
vivax will require curative treatment of hypnozoites, with subclinical infections potentially playing an important role in P. vivax transmission.
